Levine James E.

Chief Financial OfficerCardiff Oncology, Inc. (CRDF) · full profile →Form 4 · filed Sep 13, 2021
Net Buying
Open-Market Buys
$194K
Open-Market Sells
$0
Net Open-Market Flow
$194K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 10, 2021Buy(P)5K$6.62$33K5K
Sep 10, 2021Buy(P)5K$6.75$34K10K
Sep 10, 2021Buy(P)10K$6.38$64K20K
Sep 10, 2021Buy(P)5K$6.35$32K25K
Sep 10, 2021Buy(P)5K$6.32$32K30K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-21-018433) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about CRDF insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001628280-21-018433"
Ask your agent
Use Arkolith to summarize insider buying and selling at Cardiff Oncology, Inc.
over the last 90 days and cite the filings.